SELENOP and hyperinsulinemic hypoglycemia, familial, 4: In the samples of deceased COVID-19 patients, 64.7% and 70.6% showed Se and SELENOP deficiency, respectively, whereas 39.3% and 32.6% of the samples from the survivors had to be classified as Se- and SELENOP-deficient, respectively.